Systems for delivering medications into or throughout the body are known as Drug Delivery Systems. The delivery mechanism, such as a tablet you ingest or an injection of a vaccination, is one of these technologies. Medication "packaging"—such as a micelle or a nanoparticle—that shields the drug from deterioration and enables it to reach wherever it is needed in the body is referred to as drug delivery systems. In the last several decades, medication delivery has evolved significantly, and much more advancements are projected in the upcoming years. Biomedical Engineers have made significant contributions to our knowledge of the physiological obstacles to effective drug administration and have also helped design a number of innovative drug delivery methods that have entered the clinical setting. Despite all of this development, some illness therapies continue to have unacceptably negative side effects. Drug Interactions with healthy tissues or organs can induce side effects, which can restrict our capacity to cure numerous disorders like cancer, neurological diseases, and infectious diseases. The targeted distribution of medications will be made easier and their negative effects will be lessened with further advancements in this field.
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Analytical strategies for solid-state forms in drug development
Maria Cristina Gamberini, University of Modena e Reggio Emilia, Italy
Title : Understanding drug transport in plasma: The role of protein binding
Saad Tayyab, UCSI University, Malaysia
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Search for novel biomarkers and therapeutic targets for inflammatory disease
Madhav Bhatia, University of Otago, New Zealand
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through de-sign-inspired biotech- & biopharma-driven applications and upgraded business mar-keting to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad AutĂłnoma de Baja California, Mexico
Title : Abuse-deterrent dosage form technique utilizing a fusion of innovative pharmaceuticals and ion exchange resin
Bhupendra Gopalbhai Prajapati, Parul University, India
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia